Transforming Operational Efficiency Ahead of Strategic Acquisitio

Pawel Wronski was engaged by Strides Arcolab, a global B2B pharmaceutical manufacturer, to prepare one of its production facilities for a strategic acquisition. The site faced multiple challenges: a narrow product portfolio, underutilized capacity, and regulatory constraints that delayed new product launches. Lengthy contract development cycles contributed to negative EBITDA and cash flow pressures, while outdated workforce practices slowed production and limited responsiveness.

Our Approach

EVERGO deployed a senior transformation team to assess the site’s operational bottlenecks and design a performance uplift strategy. We focused on portfolio expansion, throughput optimization, and workforce modernization — all aligned with regulatory readiness and commercial growth targets.

Results Achieved

• Revenues doubled within three years, enabling the site to reach operational break-even
• Production volume increased by 250%, unlocking full capacity utilization
• SKU count grew from 34 to 111, a 300% + expansion in product diversity
• The facility passed a positive US FDA inspection, validating quality and compliance improvements

Impact

This transformation positioned the site as a scalable, acquisition-ready asset with strong financials, regulatory credibility, and operational resilience. It exemplifies our ability to deliver measurable performance gains in complex manufacturing environments — turning underperforming facilities into strategic growth platforms.